ADGRL4+ renal tubule cells, which were highly metastatic and invasive, might be an essential cell subcluster for ccRCC, and ADGRL4 could be used a novel therapeutic target. This evidence concerns the gene ADGRL4 and nonpapillary renal cell carcinoma.